1,528
Participants
Start Date
March 27, 2023
Primary Completion Date
December 2, 2025
Study Completion Date
December 2, 2025
Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
Liquid solution - intramuscular
Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Liquid solution - intramuscular
Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV)
Oral suspension - oral
Pneumoccocal Vaccine
Suspension for injection - intramuscular
Measles, Mumps, and Rubella Vaccine live (MMR)
Lyophilized powder for injection - subcutaneous
DTwP-HepB-Hib-IPV vaccine
Suspension - intramuscular
DTaP-IPV-Hib-HepB vaccine
Liquid solution - intramuscular
Hepatitis A vaccine
Lyophilized powder for injection - subcutaneous
Rotavirus vaccine
Oral solution - oral
Typhoid conjugate vaccine (TCV)
Suspension for injection - intramuscular
Measles vaccine
Freeze-dried powder for reconstitution and injection - subcutaneous
Varicella vaccine live
Sterile powder and diluent for injection - subcutaneous
Varicella vaccine live
Lyophilized powder for injection - subcutaneous
Measles, Mumps, and Rubella Vaccine live (MMR)
Lyophilized powder for injection - subcutaneous
Hepatitis A vaccine
Suspension for injection - intramuscular
Investigational Site Number : 7100001, Middelburg
Investigational Site Number : 7100005, Johannesburg
Investigational Site Number : 7100006, George
Investigational Site Number : 7100002, Cape Town
Investigational Site Number : 7100003, Cape Town
Investigational Site Number : 3560003, New Delhi
Investigational Site Number : 3560016, Kanpur
Investigational Site Number : 3560002, Pune
Investigational Site Number : 3560001, Pune
Investigational Site Number : 3560007, Hyderabad
Investigational Site Number : 3560013, Mysore
Investigational Site Number : 3560004, Mysore
Investigational Site Number : 3560011, Manipal
Investigational Site Number : 3560006, Chennai
Investigational Site Number : 3560009, Kolkata
Sanofi Pasteur, a Sanofi Company
INDUSTRY